EngenderHealth

About: EngenderHealth is a nonprofit organization based out in Washington D.C., District of Columbia, United States. It is known for research contribution in the topics: Population & Family planning. The organization has 190 authors who have published 187 publications receiving 6549 citations.

Authoring identity amidst the treacherous terrain of science: A multiracial feminist examination of the journeys of three women of color in science

Abstract: The study of the identity processes of women of color in science-based fields helps us (a) find ways to support similar women, and (b) study the dynamics of inequity, within and beyond science. Participants in this study (a Black woman, a Latina, and an American Indian woman) survived inadequate high schools and discouraging college science departments to win formal recognition (fellowships, publications). Using multiracial feminist theory, including intersectionality, and practice theory, we conceptualize authoring of identity as an ongoing process. Qualitative methods were designed around Black feminist precepts of caring and personal accountability, the use of concrete experience and of dialogue (Collins, 2000a). Participants' opportunities to author legitimate science identities were constrained by their location in the matrix of oppression. They reported conflicts between their identities as women of color and as credible science students, and having racist, sexist identities ascribed to them. All became more adept at fending off negative ascription and all found settings with less identity conflict; their ability to read a situation and quickly adjust, la facultad (Anzaldua, 1999) helped them survive. But the fact that they have needed to do this is unjust.

Direct visual inspection for cervical cancer screening: an analysis of factors influencing test performance.

Abstract: BACKGROUND The authors evaluated direct visual inspection of the cervix after the application of 5% acetic acid (DVI) as a cervical cancer screening test for use in low-resource settings METHODS Four tests were used to screen 2754 previously unscreened women: DVI with and without ×45 magnification and differentiating between all lesions and well-circumscribed lesions; testing for high-risk types of human papillomavirus DNA using the Hybrid Capture II assay, cervical cytology, and Cervicography™ Women with positive results on any of the four screening tests were referred for colposcopy and histologic sampling All women were tested for N gonorrhea, C trachomatis, T vaginalis, and human immunodeficiency virus 1 RESULTS Histologically confirmed carcinoma was diagnosed in 21 women (08%), high-grade squamous intraepithelial lesions (SILs) were diagnosed in 96 women (35%), and low-grade SILs were diagnosed in 102 women (37%) The estimated sensitivity of DVI when performed without magnification for high-grade SILs was 70%, with an estimated specificity of 79% Magnification did not significantly improve sensitivity for high-grade SILs (74% with magnification) but significantly reduced specificity (77%) Restricting the definition of a positive DVI test to a well-defined acetowhite lesion reduced sensitivity and significantly improved specificity Infection with T vaginalis, N gonorrhea, and C trachomatis did not alter sensitivity or specificity CONCLUSIONS This study confirmed the utility of DVI as a primary screening test Evaluation of the clinical effectiveness of screening with this low-cost and simple test in low-resource settings is necessary Cancer 2002;94:1699–707 © 2002 American Cancer Society DOI 101002/cncr10381